Compound Report Overview
          
          
            
              Compound Name: 
              ()-4-ALPHA(R)-4-ALLYL-2(S)5(R)-DIMETHYLPIPERAZIN-1-YL-3-METHOXYBENZYL-N-ETHYL-N-METHYLBENZAMIDE DIHYDROCHLORIDE
            
           
          
          
          
            
              Compound Identifier: 
              706302
            
           
          
          
          
          
          
          
          
          
          
          
          
          
            
              Development Status: 
              Clinical Phase IIIII
            
           
          
          
          
            
              SMILES: 
              CCN(C)C(O)c1ccc(cc1)C(N2CC(C)N(CCC)CC2C)c3cccc(OC)c3